HealthDay News — Screening detection is associated with increased survival rates even for stage IV breast cancer, according to a study published online Feb. 19 in the Journal of the National Cancer ...

HealthDay News — A blood test designed to find cancer early did not work as hoped in a major new study, according to the company that makes it. The test, called Galleri, failed to lower the number of ...

The approval was based on a cohort of treatment-naïve patients in the Beamion LUNG-1 trial who had unresectable or metastatic, non-squamous NSCLC with HER2 tyrosine kinase domain mutations.

In the phase 3 VERIFY trial, rusfertide was associated with a significantly higher proportion of patients achieving clinical response compared with placebo.

Researchers explain Care Coordination and Collaboration Programs in Oncology, which use patient navigators to ease disparities in cancer care for Native American patients.

This study introduced patients with HCC post TACE to an internet-based mindfulness-based interventions and sought their perceptions of the experience.

In this study, researchers aimed to determine whether overall survival is superior with first-line CDK4/6i use compared to second-line use in HR-positive, HER-negative advanced breast cancer.

Investigators sought to determine the effect of “Smart PSA” guidelines on screening behavior and biopsy outcomes among Black men.

In the AMPLIFY study, fixed-duration venetoclax-acalabrutinib reduced the risk of disease progression or death by 35% compared with chemoimmuntherapy.

SHERBET, an individual patient data post hoc pooled analysis of 5 prospective trials, compared HDR-BT with SBRT in patients with intermediate-risk prostate cancer.

Chenxi Jiang, M.P.H., from the American Cancer Society in Atlanta, and colleagues used data from the U.S. Cancer Statistics Database to compare differences in cervical cancer incidence rates for women ...

This study investigated the outcomes of perioperative multidisciplinary nursing collaboration for patients who underwent laparoscopic radical prostatectomy.